866-997-4948(US-Canada Toll Free)

Genentech, Inc. - Product Pipeline Analysis, 2015 Update

Published By :

GlobalData

Published Date : Feb 2015

Category :

Biotechnology

No. of Pages : 54 Pages


Genentech, Inc. (Genentech) is one of the world's leading biotech companies. The company undertakes research, development, manufacture, and marketing of biotherapeutics. Genentech focuses on developing drugs for unmet medical needs in the areas of cancer, immunological diseases and angiogenic disorders. Some of its major products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme and Activase. Its research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience. Its clinical development pipeline includes small molecules, monoclonal antibodies, and antibody drug conjugates. The company operates as a wholly owned subsidiary of Roche following its acquisition in 2009. The company is headquartered in South San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Genentech, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents  2
List of Tables  4
List of Figures  5
Genentech, Inc. Company Snapshot  6
Genentech, Inc. Company Overview  6
Key Information  6
Genentech, Inc. Pipeline Products and Clinical Trials Overview  7
Genentech, Inc. – Pipeline Analysis Overview  10
Business Description  10
Key Facts  10
Genentech, Inc. - Major Products and Services  11
Genentech, Inc. Pipeline Products by Development Stage  13
Genentech, Inc. Pipeline Products Overview  16
Akt Inhibitor Companion Diagnostic Assay  16
Akt Inhibitor Companion Diagnostic Assay Product Overview  16
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay  17
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay Product Overview  17
Anti-IL17 Mab Companion Diagnostic Assay  18
Anti-IL17 Mab Companion Diagnostic Assay Product Overview  18
Anti-PDL1 Mab Companion Diagnostic Assay  19
Anti-PDL1 Mab Companion Diagnostic Assay Product Overview  19
Arbaclofen Companion Diagnostic Assay  20
Arbaclofen Companion Diagnostic Assay Product Overview  20
Bevacizumab Companion Diagnostic Assay  21
Bevacizumab Companion Diagnostic Assay Product Overview  21
ChK1 Inhibitor - GDC-0425 Companion Diagnostic Assay  22
ChK1 Inhibitor - GDC-0425 Companion Diagnostic Assay Product Overview  22
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay  23
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay Product Overview  23
Cobimetinib Companion Diagnostic Assay  24
Cobimetinib Companion Diagnostic Assay Product Overview  24
Crenezumab - Anti-Abeta Companion Diagnostic Assay  25
Crenezumab - Anti-Abeta Companion Diagnostic Assay Product Overview  25
Erlotinib Companion Diagnostic Assay  26
Erlotinib Companion Diagnostic Assay Product Overview  26
GDC-0994 - Companion Diagnostic Assay  27
GDC-0994 - Companion Diagnostic Assay Product Overview  27
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay  28
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay Product Overview  28
Lebrikizumab Companion Diagnostic Assay  29
Lebrikizumab Companion Diagnostic Assay Product Overview  29
MEK Inhibitor -  GDC-0973 Companion Diagnostic Assay  30
MEK Inhibitor -  GDC-0973 Companion Diagnostic Assay Product Overview  30
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay  31
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay Product Overview  31
Omalizumab Companion Diagnostic Assay  32
Omalizumab Companion Diagnostic Assay Product Overview  32
PI3 Kinase Inhibitor - GDC-0032 Companion Diagnostic Assay  33
PI3 Kinase Inhibitor - GDC-0032 Companion Diagnostic Assay Product Overview  33
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay  34
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay Product Overview  34
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay  35
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay Product Overview  35
Pictilisib - GDC-0941 Companion Diagnostic Assay  36
Pictilisib - GDC-0941 Companion Diagnostic Assay Product Overview  36
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay  37
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay Product Overview  37
Ranibizumab Companion Diagnostic Assay  38
Ranibizumab Companion Diagnostic Assay Product Overview  38
Rontalizumab - Anti-INF alpha Mab Companion Diagnostic Assay  39
Rontalizumab - Anti-INF alpha Mab Companion Diagnostic Assay Product Overview  39
Tocilizumab Companion Diagnostic Assay  40
Tocilizumab Companion Diagnostic Assay Product Overview  40
Tofogliflozin Companion Diagnostic Assay  41
Tofogliflozin Companion Diagnostic Assay Product Overview  41
TV-45070 Companion Diagnostic Test  42
TV-45070 Companion Diagnostic Test Product Overview  42
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer  43
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer Product Overview  43
Vismodegib Companion Diagnostic Assay  44
Vismodegib Companion Diagnostic Assay Product Overview  44
Genentech, Inc. - Key Competitors  45
Genentech, Inc. - Key Employees  46
Genentech, Inc. - Key Employee Biographies  47
Genentech, Inc. - Locations And Subsidiaries  48
Head Office  48
Other Locations & Subsidiaries  48
Recent Developments  49
Genentech, Inc., Recent Developments  49
Jan 14, 2015: Human Longevity Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples  49
Apr 07, 2014: Genentech and PatientsLikeMe Enter Patient-Centric Research Collaboration  49
Feb 19, 2014: Cogent Reports Genentech Regains Its Dominance in Image Among Oncologists  50
Feb 03, 2014: PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration  50
Oct 14, 2013: Genentech Announces Plans to Expand California Biologics Manufacturing Facilities  51
Jun 11, 2013: PDL BioPharma Files For Arbitration Against Genentech Based On Underpayment Of Royalties  51
Mar 05, 2013: Dako Receives FDA Approval For Two Assays As Companion Diagnostics For Genentech's New Breast Cancer Medicine Kadcyla  52
Mar 04, 2013: Vernalis receives a further $2.5 million payment from its drug discovery collaboration with Genentech  52
Feb 04, 2013: Vernalis Receives $1.5m Milestone Payment From Drug Discovery Collaboration With Genentech  52
Sep 19, 2012: Ten Pharmaceutical Companies Unite To Accelerate Development Of New Medicines  53

Appendix  54
Methodology  54
About GlobalData  54
Contact Us  54
Disclaimer  54

List of Table


Genentech, Inc., Key Facts  6
Genentech, Inc. Pipeline Products and Clinical Trials Overview  7
Genentech, Inc. Pipeline Products by Equipment Type  7
Genentech, Inc. Pipeline Products by Indication  9
Genentech, Inc., Key Facts  10
Genentech, Inc., Major Products and Services  11
Genentech, Inc. Number of Pipeline Products by Development Stage  13
Genentech, Inc. Pipeline Products Summary by Development Stage  14
Akt Inhibitor Companion Diagnostic Assay - Product Status  16
Akt Inhibitor Companion Diagnostic Assay - Product Description  16
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay - Product Status  17
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay - Product Description  17
Anti-IL17 Mab Companion Diagnostic Assay - Product Status  18
Anti-IL17 Mab Companion Diagnostic Assay - Product Description  18
Anti-PDL1 Mab Companion Diagnostic Assay - Product Status  19
Anti-PDL1 Mab Companion Diagnostic Assay - Product Description  19
Arbaclofen Companion Diagnostic Assay - Product Status  20
Arbaclofen Companion Diagnostic Assay - Product Description  20
Bevacizumab Companion Diagnostic Assay - Product Status  21
Bevacizumab Companion Diagnostic Assay - Product Description  21
ChK1 Inhibitor - GDC-0425 Companion Diagnostic Assay - Product Status  22
ChK1 Inhibitor - GDC-0425 Companion Diagnostic Assay - Product Description  22
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay - Product Status  23
ChK1 Inhibitor - GDC-0575 Companion Diagnostic Assay - Product Description  23
Cobimetinib Companion Diagnostic Assay - Product Status  24
Cobimetinib Companion Diagnostic Assay - Product Description  24
Crenezumab - Anti-Abeta Companion Diagnostic Assay - Product Status  25
Crenezumab - Anti-Abeta Companion Diagnostic Assay - Product Description  25
Erlotinib Companion Diagnostic Assay - Product Status  26
Erlotinib Companion Diagnostic Assay - Product Description  26
GDC-0994 - Companion Diagnostic Assay - Product Status  27
GDC-0994 - Companion Diagnostic Assay - Product Description  27
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay - Product Status  28
Lampalizumab - Anti-Factor D Fab Companion Diagnostic Assay - Product Description  28
Lebrikizumab Companion Diagnostic Assay - Product Status  29
Lebrikizumab Companion Diagnostic Assay - Product Description  29
MEK Inhibitor -  GDC-0973 Companion Diagnostic Assay - Product Status  30
MEK Inhibitor -  GDC-0973 Companion Diagnostic Assay - Product Description  30
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay - Product Status  31
MEK Inhibitor - GDC-0623 Companion Diagnostic Assay - Product Description  31
Omalizumab Companion Diagnostic Assay - Product Status  32
Omalizumab Companion Diagnostic Assay - Product Description  32
PI3 Kinase Inhibitor - GDC-0032 Companion Diagnostic Assay - Product Status  33
PI3 Kinase Inhibitor - GDC-0032 Companion Diagnostic Assay - Product Description  33
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay - Product Status  34
PI3 Kinase Inhibitor - GDC-0084 Companion Diagnostic Assay - Product Description  34
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay - Product Status  35
PI3 Kinase/mTOR Dual Inhibitor - GDC-0980 Companion Diagnostic Assay - Product Description  35
Pictilisib - GDC-0941 Companion Diagnostic Assay - Product Status  36
Pictilisib - GDC-0941 Companion Diagnostic Assay - Product Description  36
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay - Product Status  37
Quilizumab (Anti-M1 prime Mab) Companion Diagnostic Assay - Product Description  37
Ranibizumab Companion Diagnostic Assay - Product Status  38
Ranibizumab Companion Diagnostic Assay - Product Description  38
Rontalizumab - Anti-INF alpha Mab Companion Diagnostic Assay - Product Status  39
Rontalizumab - Anti-INF alpha Mab Companion Diagnostic Assay - Product Description  39
Tocilizumab Companion Diagnostic Assay - Product Status  40
Tocilizumab Companion Diagnostic Assay - Product Description  40
Tofogliflozin Companion Diagnostic Assay - Product Status  41
Tofogliflozin Companion Diagnostic Assay - Product Description  41
TV-45070 Companion Diagnostic Test - Product Status  42
TV-45070 Companion Diagnostic Test - Product Description  42
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer - Product Status  43
Vemurafenib Companion Diagnostic Assay - Thyroid Cancer - Product Description  43
Vismodegib Companion Diagnostic Assay - Product Status  44
Vismodegib Companion Diagnostic Assay - Product Description  44
Genentech, Inc., Key Employees  46
Genentech, Inc., Key Employee Biographies  47
Genentech, Inc., Other Locations  48
Genentech, Inc., Subsidiaries  48

List of Chart


Genentech, Inc. Pipeline Products by Equipment Type  8
Genentech, Inc. Pipeline Products by Development Stage  13

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *